The PI3K/PTEN pathway in innate immune responses with particular focus on atherosclerosis and rheumatoid arthritis by Hainzl, Eva
  1 
 
 
 
 
 
 
 
DIPLOMARBEIT 
 
 
 
 
Titel der Diplomarbeit 
 
 
 
The PI3K/PTEN pathway in innate immune responses with particular 
focus on atherosclerosis and rheumatoid arthritis 
 
 
 
 
 
 
angestrebter akademischer Grad 
 
Magistra der Naturwissenschaften (Mag. rer.nat.) 
 
 
 
 
 
Verfasserin / Verfasser: Eva Hainzl 
Matrikel-Nummer: 0304918 
Studienrichtung /Studienzweig 
(lt. Studienblatt): 
Genetik/Mikrobiologie 
Betreuerin / Betreuer: Thomas Decker 
 
 
 
 
Wien, im April 2009 
 
  2 
CONTENT 
 
 
CONTENT............................................................................................... 2 
ABSTRACT............................................................................................. 5 
ZUSAMMENFASSUNG .......................................................................... 6 
1. INTRODUCTION................................................................................. 7 
1.1 Signaling via the PI3K/PTEN pathway............................................................ 7 
1.1.1 The Phosphoinositide 3-kinase family ......................................................... 7 
1.1.2 Activation of PI3 kinases ............................................................................. 9 
1.1.3 Cellular processes upon PI3K activation ................................................... 10 
1.1.4 PTEN and negative regulation of PI3K signaling....................................... 11 
1.1.5 PI3K/PTEN in innate immune reactions .................................................... 12 
1.1.6 Knockout mice available to study the PI3K/PTEN pathway....................... 13 
1.2 The innate immune system........................................................................... 14 
1.2.1 Inflammation.............................................................................................. 14 
1.2.2 The human immune system ...................................................................... 15 
1.2.3 The innate immune system - receptors ..................................................... 15 
1.2.3 The innate immune system – cells of the (innate) immune system ........... 18 
1.3 Atherosclerosis.............................................................................................. 20 
1.3.1 Atherosclerosis - epidemiology ................................................................. 20 
1.3.2 Vessel wall anatomy.................................................................................. 21 
1.3.3 Atherogenesis ........................................................................................... 23 
1.3.4 Experimental systems to study atherosclerosis in mice ............................ 24 
1.3.5 A potential role for PI3K/PTEN in atherosclerosis ..................................... 25 
1.4 Arthritis........................................................................................................... 26 
1.4.1 Rheumatoid arthritis, an overview ............................................................. 26 
1.4.2 Potential role for the PTEN/PI3K pathway in rheumatoid arthritis ......... 27 
2. OBJECTIVES.................................................................................... 28 
3. MATERIALS AND METHODS .......................................................... 29 
3.1 Materials ......................................................................................................... 29 
  3 
3.2 Mice experiments........................................................................................... 30 
3.2.1 Mice handling ............................................................................................ 30 
3.2.2 Anaesthesia of mice.................................................................................. 31 
3.2.3 Induction of collagen induced arthritis in mice........................................... 31 
3.2.4 Genotyping mice ....................................................................................... 32 
3.2.5 Collection of blood..................................................................................... 34 
3.3 In vitro experiments....................................................................................... 35 
3.3.1 Isolation of peritoneal macrophages.......................................................... 35 
3.3.2 Isolation of bone marrow and differentiation of dendritic cells ................... 35 
3.3.3 Stimulation of macrophages...................................................................... 36 
3.3.4 Staining of foam cells using Oil Red O...................................................... 36 
3.3.5 Oxidation of LDL........................................................................................ 36 
3.3.6 Preparation of oxidized phospholipids for use in cell culture ..................... 37 
3.4 Isolation and staining of mouse aorta ......................................................... 37 
3.4.1 Isolation..................................................................................................... 37 
3.4.2 Staining of aorta ........................................................................................ 38 
3.5 Analysis methods.......................................................................... 38 
3.5.2 ELISA enzyme-linked immunosorbent assay - Measurement of 
Cytokines/Chemokines....................................................................................... 38 
3.6.2 Real-Time Polymerase Chain Reaction .................................................... 38 
3.6.3 Western Blotting........................................................................................ 39 
4. RESULTS.......................................................................................... 41 
4.1 PTEN in Atherosclerosis ............................................................................... 41 
4.1.1 Knockout of PTEN in LysMcre macrophages was shown on protein as well 
as mRNA level ................................................................................................... 41 
4.1.2 PTEN deficiency in macrophages results in enhanced intracellular levels of 
modified lipoprotein particles and enhanced foam cell formation ....................... 43 
4.1.3 Effects of PTEN knockout in macrophages in atherosclerosis associated 
signalling ............................................................................................................ 45 
4.1.4 Analysis of atherosclerotic plaques in en face preparations of aortas of 
LysMcre flPTEN mice......................................................................................... 47 
4.2 PTEN in Rheumatoid Arthritis ...................................................................... 49 
4.2.1 Mice deficient for PTEN in myeloid cells show significantly decreased 
symptoms for arthritis than wildtype control mice............................................... 49 
4.2.2 Reduction of inflammatory markers in plasmas of PTEN KO CIA mice but 
no effect on collagen autoantibodies level.......................................................... 51 
4.2.3 Generation of bone-marrow derived dendritic cells which showed the 
expected PTEN knockout phenotype ................................................................. 53 
  4 
4.2.4 Inflammatory cytokines are reduced in in vitro generated BM-derived PTEN 
-/- dendritic cells ................................................................................................. 55 
4.2.5 Reduced levels of all subunits of IL-12 may account for the anti-
inflammatory effect of the PTEN knockout ......................................................... 57 
4.2.6 Differential regulation of MAPK signalling might account for the 
downregulatory effects on cytokine levels by enhanced PI3K signalling ............ 59 
4.3 Manuscripts in preparation........................................................................... 61 
4.3.1 Myeloid PTEN enhances inflammation but impairs bactericidal activities 
during murine pneumococcal pneumonia........................................................... 61 
4.3.2 Anti-inflammatory properties of the PI3K pathway are mediated by 
IL10/DUSP regulation......................................................................................... 61 
5. DISCUSSION .................................................................................... 62 
5.1 Atherosclerosis.............................................................................................. 62 
5.2 Arthritis........................................................................................................... 64 
6. REFERENCES.................................................................................. 68 
CURRICULUM VITAE........................................................................... 79 
 
APPENDIX 1 
APPENDIX 2
  5 
ABSTRACT 
 
Conversion of PtdIns-4,5-biphosphate (PIP2) to PtdIns-3, 4,5-triphosphate (PIP3) by 
Phosphoinositide 3-kinases (PI3K) is crucial in various diverse cellular processes 
such as metabolism, growth, survival and migration. Phosphatase and tensin 
homologue deleted on chromosome 10 (PTEN) is the most famous opponent of PI3K 
activity. Knockout of PTEN and thus hyperactive PI3K signaling was shown to limit 
immune responses and excessive host tissue damage. We hypothesized that myeloid 
specific deletion of PTEN modulates inflammatory responses in murine models of 
chronic inflammation. 
In atherosclerosis, myeloid specific PTEN knockout led to increased foam cell 
formation in vitro independent of scavenger receptor expression. Atherosclerotic 
plaque formation was not significantly altered in mice aged 16 weeks, but an effect is 
expected to be seen in older mice. 
In rheumatoid arthritis, PTEN deficiency in myeloid cells was demonstrated to be 
beneficial for mice suffering from Collagen-induced arthritis (CIA). In this model of 
non-infectious exacerbated immune response, mice with sustained PI3K activation 
had a significantly lower or no response at all. Histology revealed less inflammation 
and bone erosion in synovial joints of PTEN -/- mice and additionally, plasma cytokine 
release was diminished. 
PTEN deficient bone-marrow derived dendritic cells also demonstrated anti-
inflammatory properties, such as reduced IL-6 production and release. Important to 
mention in this context are the diminished IL-12 and IL-23 levels, which are important 
in T helper cell differentiation. 
To sum up, PI3K signaling was shown to act anti-inflammatory and inhibition of PTEN 
might be a potent target for treatment of various autoimmune diseases such as 
rheumatoid arthritis and possibly also multiple sclerosis. 
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ZUSAMMENFASSUNG 
 
Umwandlung von PtdIns-4,5-biphosphat (PIP2) zu PtdIns-3, 4,5-triphosphat (PIP3) 
durch Phosphoinositid 3-kinasen (PI3K) ist essentiell in verschiedenen zellulären 
Prozessen wie z. B. Metabolismus, Wachstum, Überleben und Chemotaxis. 
Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) ist der 
bekannteste Gegenspieler zur PI3K Aktivität. Durch Knockout von PTEN und dadurch 
Verstärkung des PI3K Signalweges wurde bereits gezeigt, dass die Immunantwort 
und auch übermäßiger Gewebsschaden vermindert war. Daraufhin stellten wir die 
Hypothese auf, dass Defizienz von PTEN einen bedeutenden Einfluss auf die 
Immunantwort in Mausmodellen für chronische Entzündung hat. 
Im Modell für Atherosklerose führte PTEN Knockout in myeloiden Zellen zu 
verstärkter Bildung von Schaumzellen in einem Prozess unabhängig von der 
Expression von Scavenger Receptors. Die Bildung von atherosklerotischen Plaques 
war allerdings nicht signifikant verändert in 16 Wochen alten Mäusen. Wir erwarten 
aber, dass ältere PTEN Knockout Mäuse sehr wohl unterschiedlich reagieren. 
Diese Diplomarbeit zeigt, dass PTEN Defizienz in myeloiden Zellen sich günstig 
auswirkt auf KOllagen-induzierte Arthritis. In diesem Mausmodell für rheumatoide 
Arthritis zeigten Mäuse mit einer verstärkten PI3K Aktivierung signifikant reduzierte 
oder sogar keine Krankheitszeichen. In histologischen Gelenksschnitten von PTEN -/- 
Mäusen wurde verminderte Entzündung und Knochenerosion beobachtet. Außerdem 
war die Freisetzung von Zytokinen ins Plasma vermindert. 
In vitro wurden PTEN defiziente dendritische Zellen aus Knochenmark gezüchtet, 
welche auch die oben beschriebenen anti-inflammatorischen Eigenschaften, wie 
verminderte IL-6 Produktion und Freisetzung zeigten. Wichtig dabei ist auch die 
Verringerung der IL-12 und IL-23 Level, die wichtig in der T Helfer Zell 
Differenzierung wichtig sind.  
Zusammenfassend wurde gezeigt, dass der PI3K Signalweg anti-inflammatorisch 
wirkt und dass PTEN ein potentielles Zielgen zur Behandlung von 
Autoimmunkrankheiten wie rheumatoider Arthritis darstellen kann.
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1. INTRODUCTION 
1.1 Signaling via the PI3K/PTEN pathway 
 
1.1.1 The Phosphoinositide 3-kinase family 
 
Phosphoinositide 3-kinases, abbreviated PI3K, are signal-transducing lipid kinases 
that are defined as catalysing the phosphoylation of phosphoinositide PtdIns-4,5-
biphosphate (PIP2) on the D3 carbon of the inositol ring to produce PtdIns-3,4,5-
triphosphate (PIP3). (Figure 1.1)  
 
 
Figure 1.1: Schematic representation of the activation of different class 1 PI3-kinases. Class 1 A PI3K 
is activated by RTKs and consists of catalytic subunit p110α, p110β or p110δ associated with 
regulatory subunit p85α or p85β. Class 1 B PI3K is activated by GPCRs and consists of catalytic 
p110γ and regulatory p101. Both subclasses generate PI(3,4,5)P3 out of PI(4,5)P2. PTEN as a PI3K 
antagonist dephosphoylates PIP3 at position 3. (modified from (Gunzl and Schabbauer, 2008)) 
Class 1A 
PI3K: 
Class 1B 
PI3K: 
PTEN 
Receptor 
Tyrosine 
Kinase 
G-Protein 
Coupled 
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Regulatory subunit(s) 
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PI3K 
PIP2 PIP3 
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PI3Ks have been quite early correlated with viral oncoproteins (Whitman et al., 1985) 
and are since then seen as important players in human cancer. (Marone et al., 2008) 
Only recently, PI3K has shown to be implicated in the pathogenesis of inflammatory 
diseases, with effects being more or less independent form originally found PI3K 
functions such as cell growth, proliferation and survival.(Fruman et al., 1999) 
According to Domin & Waterfield, 3 main classes of PI3K were defined based on 
structure and regulation. (Domin and Waterfield, 1997) (Figure 1.2) The probably 
most important one and thus the best understood is Class I. It can be subdivided into 
class IA and class IB.  
 
 
 
Figure 1.2: The 3 different classes of PI3-Kinases as defined by Domin & Waterfield. ((Domin and 
Waterfield, 1997)) 
 
 
Class 1A enzymes consist of a catalytic domain (p110α, p110β or p110δ) associated 
with regulatory subunits (p85α, p85β, p55α, p50α or p55γ).(Fruman et al., 2000) 
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Class 1B consists of p110γ as a catalytic subunit and p101 as regulatory 
domain.(Carpenter et al., 1990) 
 
1.1.2 Activation of PI3 kinases 
 
PI3Kinases can be activated upon a plethora of stimuli including growth factors, 
cytokines, hormones and neurotransmitters. In terms of activation, there are some 
major differences between class 1A and class 1B PI3K. Whereas the first becomes 
mainly activated by receptor tyrosine kinases and ligands such as insulin or growth 
factors, the latter is stimulated by G-protein coupled receptors, which are influenced 
mainly by chemokines.(Figures 1.1 and 1.3) 
 
 
 
Figure 1.3: Simplified scheme for activation and downstream effects of PI3K.(Marone et al., 2008) 
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1.1.3 Cellular processes upon PI3K activation 
 
 
 
 
Figure 1.4: Summary of the PI3K-Akt signalling pathway (by Cell Signaling technologies) 
 
The formation of PIP3 leads to the activation of downstream targets containing a 
pleckstring homology (PH) domain. The most important in this context is Akt, also 
known as protein kinase B (PKB), which is a serine/threonine protein kinase 
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discovered in 1995.(Franke et al., 1995) Burgering and Coffer first suggested a role 
for Akt/PKB in PI3K signal transduction by inhibiting PI3K with Wortmannin and PI3K 
silencing. (Burgering and Coffer, 1995) 
Akt has now been reported to be involved in many cellular processes, notably cell 
proliferation and survival. Today there are 3 isoforms of Akt described: AKT1/PKBα, 
AKT2/PKBβ and AKT3/PKBγ, which are all highly homologous in terms of peptide 
sequence. (Manning and Cantley, 2007) Through binding to PIP3, Akt is 
phosphoylated at Thr308 and Ser473, mainly by PDK1 (phosphoinositide dependent 
kinase 1) and mTORC2 (mammalian target of rapamycin complex 2).  
 
Phosphoylated Akt then influences a variety of downstream genes depicted in figure 
1.4, for example inhibition of GSK-3 and Bad, which are responsible for the anti-
apoptotic effects of PI3K. Akt is considered as a classical oncogene, as many 
regulated genes influence cell growth, proliferation and survival. 
 
Negative regulation of Akt signaling can happen directly via dephosphoylation by 
PHLPP or indirectly through inhibition of PI3K signaling. 
 
 
1.1.4 PTEN and negative regulation of PI3K signaling 
 
A negative regulator of the PI3K pathway is the phosphatase and tensin homologue 
deleted on chromosome 10, abbreviated PTEN. PTEN antagonizes PI3K by removing 
a phosphate group from PI(3,4,5)P3 to generate PI(4,5)P2. It has originally been 
found as an important tumour suppressor gene, as it stops PI3K-mediated 
proliferation and survival, but is now also seen as important in inflammatory context. 
(Li et al., 1997; Suzuki et al., 2001) It is a dual-specificity phosphatase and hydrolyzes 
ester bonds on thyrosine and serine/threonine residues of lipid substrates. (Myers et 
al., 1997) 
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Regulation of PTEN takes place at multiple levels, the most prominent one being 
probably phosphoylation and thus inactivation by casein kinase II. (Gericke et al., 
2006) 
Another inositol phosphatase family is SHIP (Src homology 2-containing-inositol 5'-
phosphatase).(Kalesnikoff et al., 2003) 
 
 
1.1.5 PI3K/PTEN in innate immune reactions 
 
It is still a controversially debated issue in research whether the PI3K/PTEN pathway 
acts predominantly pro- or anti-inflammatory. Using pharmacologic inhibition of PI3K 
signalling by the fungal metabolite Wortmannin or by the synthetic inhibitor 
LY294002, different studies found proofs for reduced as well as enhanced pro-
inflammatory gene expression. These contradictory effects might be explained by 
non-specific inhibition of targets other than PI3K. (Gunzl and Schabbauer, 2008) 
Using genetically modified mice, a clearer picture of the involvement of PI3K in innate 
immune responses can be drawn. In p85 alpha deficient cells, IL-12 expression upon 
TLR stimulation has been shown to be elevated. (Fukao et al., 2002) Yu et al. 
demonstrated that flagellin induced activation of PI3K via TLR5 and that chemical 
inhibition of PI3K as well as PI3K knockout in mice induced MAPK activation followed 
by enhanced expression of proinflammatory genes such as IL-6 and KC. (Yu et al., 
2006) In complete PI3K knockout mice generated by L. Cantley and in PTEN deficient 
cells it was shown that the PI3K-Akt pathway inhibits MAPK activation upon LPS 
stimulation, but that the NF-kappaB pathway was only marginally affected. (Luyendyk 
et al., 2008) Contrary to this are findings made by Artin et al. who claim that AKT and 
GSK3b have a direct effect on NF-kappaB activity. (Martin et al., 2005)  
In terms of inflammatory modulators, reduction in PI3K signalling leads to elevated 
TNF-alpha and IL-6 levels. (Luyendyk et al., 2008) In animal models of sepsis it has 
been shown that inhibition of PI3K by Wortmannin leads to increased cytokine 
production and reduced survival time in endotoxemia or cecal ligation and puncture-
induced polymicrobial sepsis. (Schabbauer et al., 2004; Williams et al., 2004) 
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PTEN has also recently become of interest in migration of neutrophils, where it 
functions as a discriminator that prioritizes responses to different chemoattractant 
signals. (Heit et al., 2008) This migratory defect has also been observed in our 
studies using flPTEN LysMcre mice in pneumonia. (Matt et al., manuscript in 
preparation) 
Recent data obtained in our laboratory suggest that the anti-inflammatory properties 
of the PI3K pathway are at least in part mediated by IL10/DUSP regulation. (Günzl et 
al., manuscript in preparation) Figure 1.5 depicts our current working hypothesis. 
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Figure 1.5: PI3K negatively regulates TLR signalling by dampening the MAP-Kinase response through 
regulation of DUSP1 on mRNA and protein level. (Günzl et al., manuscript in preparation) 
 
 
1.1.6 Knockout mice available to study the PI3K/PTEN pathway 
In this diploma thesis, different types of knockout mice were used. To study PTEN 
function, a complete knockout mouse has been designed by Cristofano et al. (Di 
Cristofano et al., 1998) As it shows embryonic lethality at approximately day 7.5, 
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conditional PTEN knockout mice using the cre-loxP system have been developed. To 
study the function of myeloid cells in immune function, we used PTEN fl/fl LysMcre 
mice in which the PTEN gene is excised after induction of the Lysozyme M promoter. 
(Clausen et al., 1999)  
Another mouse strain using cre recombinase is the ap2cre flPTEN mouse, where 
PTEN is specifically excised in adipose tissue. (Kurlawalla-Martinez et al., 2005) 
Recent results obtained using conditional PTEN knockout mice have been reviewed 
by Suzuki et al. (Suzuki et al., 2008) 
For PI3K itself, many different strains are available. Of particular interest for our 
research purposes was the PI3K class 1A subunit p85α, for which two different 
knockout strains have been developed in the past. The first, published by L. Cantley 
(Fruman et al., 2000), lacks all isoforms (p85 alpha, p55 alpha and p50 alpha) and 
shows perinatal lethality with only a fraction of animals surviving the first weeks 
postnataly. One of the most obvious phenotypes of this mouse is excessive liver 
necrosis. The second available p85α-deficient mouse strain, developed by S. 
KOyasu, still expresses the smaller variants of p85α, namely p50α and p55α, leading 
to a quite normal phenotype. It can thus be concluded that these isoforms can at least 
partially compensate for the deletion of the full gene product. (Terauchi et al., 1999) 
 
 
1.2 The innate immune system 
 
1.2.1 Inflammation  
 
Inflammation (Latin: inflammo – to set on fire) is the reaction of the body to noxious 
stimuli and conditions such as infections and tissue injury. (Medzhitov, 2008) Its 
primary goal is to remove potentially dangerous substances and allow tissue 
regeneration.  
Inflammation can be subdivided into acute and chronic forms. Acute inflammation 
represents the immediate answer of the body to invading pathogens or tissue injury 
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and is usually cleared within a period of a few days. If however the inflammatory 
stimulus, e.g. allergens, bacteria or chemicals, persists, the inflammation cannot be 
resolved. This situation is then called chronic inflammation. Another example of a 
pathological situation is dysregulated inflammation as it is the case in septic patients. 
 
1.2.2 The human immune system 
The human immune system with its two arms, innate and adaptive, has to fulfil the 3 
basal principles to help its host survive: (Beutler, 2004) 
• Recognition of pathogens (as many as possible) 
• Kill pathogens upon recognition 
• Establish self-tolerance 
In this system, mechanisms and cells of innate immunity provide initial defense and 
act within hours upon infection. It consists mainly of physical barriers, phagocytes, 
complement, NK cells and its respective receptors and will be discussed in greater 
detail later on. As a contrast, adaptive immune responses are more specific and act 
later on in the time course of infection. The respective cells are T and B cells, but also 
antibodies as the humoral part. (Medzhitov and Janeway, 1998) As our research 
mainly focused on innate innate immune responses and T helper cell activation, the 
other components of the adaptive immune system will not further be described. 
 
 
1.2.3 The innate immune system - receptors 
 
1.2.3.1 Pattern recognition receptors 
Pattern recognition receptors (PRRs) are receptors of the innate immune system that 
recognize pathogen-associated molecular patterns (PAMPs) and trigger antimicrobial 
functions of leukocytes. (Medzhitov, 2001) These receptors can either be membrane-
bound, cytoplasmatic or secreted components. Examples for such receptors are toll-
like receptors (TLRs), scavenger receptors and NOD-like receptors (NLRs). 
(Medzhitov, 2008) 
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1.2.3.2 Toll-like receptors 
TLRs have been first described by Medzhitov et al. in 1997 as human homologues of 
the Drosophila melanogaster protein toll and were shown to activate the NF-kappaB 
pathway and subsequently adaptive immune system. (Medzhitov et al., 1997) 
Probably the most prominent example for a PRR-PAMP interaction is the recognition 
of the bacterial endotoxin lipopolysaccharide (LPS) by TLR-4, first described by B. 
Beutler’s group in 1998. (Poltorak et al., 1998) For correct recognition of LPS, 
accessory molecules like LBP (LPS binding protein), CD14 and MD-2 are necessary. 
(Medzhitov, 2001) TLR-2 recognizes a wide variety of microbial surface products as 
summarized in figure 1.6. This is possible due to interaction with TLR1 and TLR6. 
TLR-3 is predominantly expressed in dendritic cells and has been shown to recognize 
dsRNA. (Alexopoulou et al., 2001) TLR-5 is a sensor for bacterial flagellin which in 
turn activates the NF-kappaB pathway and thus TNF-alpha. (Hayashi et al., 2001) 
Another innate immune receptor is TLR-9 which recognizes unmethylated CpG DNA. 
(Hemmi et al., 2000) 
 
Figure 1.6: Toll-like receptors recognize a variety of pathogens, for example microbial surface proteins 
such as LPS, Flagellin or PGN. (Medzhitov, 2001) 
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Signalling downstream of TLRs is often shared and requires MyD88, TOLLIP (Toll-
interacting protein), IRAK (IL-1R associated kinase) and TRAF-6 (TNF-receptor 
associated factor 6). Toll-like receptors are also seen as important activators of 
adaptive immunity as summarized in figure 1.7. 
 
 
Figure 1.7: TLRs expressed on dendritic cells (DCs) are important stimulators of the adaptive immune 
system. Pathogens bind to Pathogen Recognition Receptors (PRRs)/TLRs on DCs and stimulate naïve 
T cells through direct interaction or release of cytokines. As a consequence, T cells differentiate into 
different subtypes such as Th1 or Th2.  (Medzhitov, 2001) 
 
 
1.2.3.3 Scavenger receptors 
Scavenger receptors (SRs) are a six subgroups comprising family of glycoproteins 
present on the cell surface that were originally defined by binding modified low 
density lipoproteins (mLDL). SRs play important roles in atherogenesis but also more 
  18 
general in innate immune regulation by macrophages. (Peiser and Gordon, 2001) The 
principal receptors responsible for uptake of modified LDL into macrophages and 
subsequent foam cell formation are SR-A and CD36. (Kunjathoor et al., 2002) 
According to Peiser and Gordon, SRs not only play a role in endocytosis of mLDL, but 
also in adhesion, phagocytosis and pattern recognition. (Peiser and Gordon, 2001) 
Oxidized phospholipids, especially four oxidized 1-palmitoyl-2-arachidonyl-
phosphatidylcholine (oxPAPC) species, have been shown to serve as ligands for SR 
CD36 and are enriched in atherosclerotic lesions. (Podrez et al., 2002a; Podrez et al., 
2002b)  
 
 
1.2.4 The innate immune system – cells of the (innate) immune system 
 
1.2.4.1 Macrophages 
Macrophages are mononuclear phagocytes derived from blood monocytes that 
belong to the myeloid lineage of leukocytes. They are present all over the body and 
appear as diverse species in different organs, for example brain microglial cells or 
Kupffer cells present in the liver. (Beutler, 2004) Also for research purposes, different 
macrophage lineages have to be considered, like alveolar, bone-marrow-derived, 
thioglycollate-elicited, or osteoclasts. 
Macrophages as well as dendritic cells play an essential role in the initial phase of 
inflammation as they recruit polymorphonuclear leukocytes (neutrophils, basophils, 
eosinophils) to the site of infection. (Beutler, 2004) Macrophages are also able to 
engulf and kill cells, but the more specialized cells to do this task are neutrophils, 
which are short-lived cells present in high numbers in conditions of severe infection. 
In terms of activation of the adaptive immune response, myeloid cells of the innate 
immune system play a vital role as antigen presenting cells (APCs) and in producing 
pro-inflammatory cytokines such as IL-12, CD40L, IL-1, type I interferons, and TNF. 
(Beutler, 2004) 
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1.2.4.2 Dendritic cells 
Dendritic cells are cells of myeloid or lymphoid origin that were first described in 1973 
as cells similar to macrophages present in small numbers lymphoid organs. 
(Steinman and Cohn, 1973) Dendritic cells (DC) are now known to influence many 
different classes of lymphocytes (T, B, NK cells) and many types of T cell responses 
(Th1/Th2/Th17, regulatory T cells, peripheral T cell deletion). (Lebre and Tak, 2008) 
In their function as professional antigen presenting cells, they migrate to the T cell 
zones in lymphoid organs and activate T cells to respond to antigen by secreting 
cytokines and by direct cell-cell contact via B7 receptor (on DC) – CD28 (on 
lymphocyte) interaction. (Guermonprez et al., 2002) 
 
1.2.4.3 T helper cells  
T cells are divided into CD8 positive cytotoxic and CD4 positive T helper cells. It has 
long been established, that T helper cells can further be separated into Th1 and Th2 
subsets. In this respect, IL-12 is an important cytokine that drives CD4 positive T cells 
into Th1 helper cell differentiation, which then produce IFN-gamma. The Th1 driven 
immune response is cell-mediated, B-cells mainly produce opsonising IgG antibodies, 
pathogens are immediately destroyed with the side effect of massive tissue 
destruction. (Szabo et al., 2003) There is no evidence for a Th2-inducing cytokine in 
dendritic cells that induce Th2 differentiation, but it is assumed, that indirect effects 
such as inhibition of IL-12 production by IL-10 favour a Th2 response. (Moser and 
Murphy, 2000) Th2 cells are important in humoral immunity and are thought to play a 
role in allergy pathogenesis. 
Only recently, a new subtype of Th cells has been described. Its main characteristic is 
that it produces IL-17 and is thus called Th17. Originally described in 2005, 
development and function of Th17 cells now provide a fast-evolving area of research. 
(Harrington et al., 2005) The main stimulus for Th17 cell development seems to be IL-
6, but also mediated at least in part by TGF-beta and IL-1. IL-23 is thought to be 
essential in final steps of Th17 differentiation. (Dong, 2008) 
The process of differentiation is summed up in figure 1.8. 
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Figure 1.8: Differentiation of naïve CD4 positive T cells to T helper cell subsets. (Dong, 2008) 
 
 
 
 
1.3 Atherosclerosis 
 
1.3.1 Atherosclerosis - epidemiology 
 
Cardiovascular disease (CVD) is still the single most common cause of death in 
Western countries. (Heald et al., 2006) As an example, 38% of all deaths in the 
United States in 2001 were due to CVD. (Murray et al., 2006) Among these, coronary 
heart disease and stroke account for the major part. Ischaemic heart disease and 
cerebrovascular disease are the leading causes of death in low- as well as high-
income countries. (Figure 1.9) 
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Figure 1.9: Death rates by disease group and region in 1990 and 2001 for adults aged 15–59 years. 
The red areas represent cardiovascular diseases, which are the most common cause of death in 
Europe and Central Asia. (Lopez et al., 2006) 
 
Most important risk factors for these diseases are high arterial blood pressure, 
elevated cholesterol and glucose levels and cigarette smoking. (Devereux and 
Alderman, 1993) As the number of risk factors increases, so does the severity of 
atherosclerosis, even in young people. (Berenson et al., 1998) 
Atherosclerosis as a disease affecting the blood vessels is seen as the main 
physiological contributor to CVD. The relationship between hypercholesteraemia and 
atheroma formation has been established for a long time. A more recent approach is 
the association of inflammatory processes and atherogenesis. (Libby, 2002) 
 
1.3.2 Vessel wall anatomy 
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Atherosclerosis is a disease caused by accumulation of lipids and fibrous elements in 
the large arteries. (Libby, 2002) To further describe formation of these lesions, known 
as atherosclerotic plaques, basic microscopic anatomy of the arterial wall is 
necessary. 
Directly surrounding the arterial lumen is the intima, which consists of a single 
epithelial layer and a basement membrane. The middle layer, called media, contains 
mainly smooth muscle cells embedded in extracellular matrix. The outermost layer is 
the tunica externa, also known as adventitia, composed of connective tissue. The 
layers are separated by internal and external elastic laminae.  (Figure 1.10) 
 
 
Figure 1.10: Anatomy of a healthy vessel wall: Surrounding the vessel lumen are Intima, Media and 
Adventitia, each separated by elastic laminae. (Picture from http://radiopaedia.org/articles/histology-of-
blood-vessels)  
 
 
In pathological situations, different inflammatory cells, dead cells and cholesterol 
accumulate in the arterial intima and thus form an atherosclerotic plaque. A schematic 
view of an advanced atherosclerotic plaque is depicted in figure 1.11. 
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Figure 1.11: Content of an atherosclerotic plaque. Accumulation of lipid loaden foam cells and 
macrophages in the arterial intima is the main characteristic of an atherosclerotic plaque. In late 
lesions, cellular debris and cholesterol accumulate in the necrotic core. (Hansson and Libby, 2006) 
 
1.3.3 Atherogenesis 
 
Atherosclerotic plaque formation starts with expression of vascular cell-adhesion 
molecule 1 (VCAM-1) on endothelial cells, caused by intimal cholesterol 
accumulation. (Cybulsky et al., 2001) VCAM-1 is the main contributor to attract 
monocytes and later also T lymphocytes to the endothelium. After adhering to the 
endothelium, monocytes start entering the intima. Responsible for this process is 
mainly the chemokine macrophage chemotactic protein-1 (MCP-1). (Gu et al., 1998)  
Macrophage colony-stimulating factor (M-CSF) then allows intimal monocytes to 
differentiate into mature macrophages. This is accompanied by enhanced expression 
of scavenger receptor A (SRA) and CD36. Through these cell surface receptors, 
macrophages are able to take up lipids from the periphery and form so-called foam 
cells, named after their characteristic lipid-laden cytoplasmatic droplets. In advanced 
lesions, death of foam cells and resulting cell debris leads to further inflammation 
which worsens the outcome.  
Figure 1.12 nicely summarises the role of mononuclear phagocytes in atherogenesis. 
  24 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.12: The role of macrophages in atherosclerotic plaque development: Blood monocytes are 
recruited to the arterial intima by VCAM-1. MCP-1 then drives migration of monocytes into the intima. 
Monocytes then differentiate into macrophages and take up modified lipoprotein particles via 
scavenger receptors, forming foam cells. (Libby, 2002) 
 
Histologically, different stages of plaque formation can be distinguished: The initial 
lesion with only isolated foam cells is present in almost every individual. Also the 
slightly advanced fatty streaks are no major problem in terms of CVD risk. It starts 
getting dangerous in the conversion of early to advanced atheromas, which is mainly 
characterized by thinning of the fibrous cap. Thin fibrous caps are prone to rupture, 
resulting in thrombosis and its possible clinical complications, mainly myocardial 
infarction. (Libby, 2002) 
In all these processes, immune responses, innate as well as adaptive mechanisms, 
are involved. (Libby et al., 2002) 
 
1.3.4 Experimental systems to study atherosclerosis in mice 
 
Up to now, two different animals have proven to be particularly useful to mimic 
atherosclerotic processes in mice. Knockout of the gene for apolipoprotein E (ApoE), 
  25 
a key component of the cholesterol metabolism in mice leads to development of 
spontaneous hypercholesteraemia and atherosclerotic disease patterns. (Plump et 
al., 1992) Feeding mice an atherogenic, Western-type diet further enhances this 
process. Another model is deficiency for the low-density-lipoprotein receptor (LDLR) 
which is usually intensified by feeding of a high fat diet to develop sufficient 
hypercholesteraemia and atherosclerotic plaques. (Hansson and Libby, 2006) In this 
context it is important to mention that, contrary to humans, cardiovascular events are 
not observed in dyslipidemic mice because mice usually keep their thick fibrous cap. 
To assess the effect of possible atherosclerosis-related genes, cross-breeding with 
ApoE -/- mice or bone marrow transplantation in LDLR -/- mice can offer important 
insights.  
 
 
1.3.5 A potential role for PI3K/PTEN in atherosclerosis 
 
Biwa et al. showed that stimulation of macrophages with oxidized LDL leads to 
activation of the PI3K signalling axis and that this further induces proliferation of 
macrophages using the pharmacologic PI3K inhibitor Wortmannin. (Biwa et al., 2000) 
Also Joe Witztum showed activation of PI3K and downstream AKT signaling by 
minimally oxidized LDL. (Miller et al., 2005; Miller et al., 2003)  
Also clinically efficient lipid lowering drugs, the HMG-CoA reductase inhibitors, known 
as statins were shown to activate PI3K signalling. (Dimmeler et al., 2001)  
In terms of in vivo studies, L. Cantley’s group demonstrated that deletion of the gene 
for PI3K subunit p110 gamma attenuates murine atherosclerosis. (Chang et al., 2007)  
In terms of the PI3K signalling regulator, no effect on atheroma development in ApoE 
-/- PTEN haplodeficient mice could be seen. (Andres et al., 2006) But as PTEN 
heterozygosity does not always show an effect, full PTEN knockout mice have to be 
studied. 
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1.4 Arthritis 
 
1.4.1 Rheumatoid arthritis, an overview 
 
Arthritis (Greek for joint inflammation) is one of the leading causes of disability in 
people aged over 55 years. Different forms of this disease are described, subdivided 
by the main cause of joint destruction. The most common type is osteoarthritis, which 
is usually caused by trauma of the joint, joint infection or age. Examples for other 
primary forms of arthritis are rheumatoid arthritis (RA), gout and septic arthritis.  
Parts of this diploma thesis focus on rheumatoid arthritis, which is described as a 
chronic autoimmune disorder and affects about 1% of the Western population. (Lebre 
and Tak, 2008) Clinical symptoms of rheumatoid arthritis are pain, swelling, stiffness 
and loss of function of the joints. Areas that are most often impaired by RA are higher 
extremities, especially joints of the hands and fingers, but as the disease progresses, 
also other joints of the body can be inflamed. Epidemiologically, women are 3 times 
more affected than men and in contrast to osteoarthritis, also younger individuals are 
subjects to RA. 
Current therapy focuses to alleviate symptoms, reduce joint destruction and prevent 
disease onset. Disease modifying antirheumatic drugs (DMARDs) are defined as 
useful drugs to slow down rheumatoid arthritis disease progression. The most 
important ones currently in use are methotrexate and different TNF inhibitors. 
To study physiological processes in RA, the animal model of collagen induced 
arthritis (CIA) is probably most useful to provide new insights into disease 
progression. In this model, collagen II is injected into mice aged 4-12 weeks together 
with complete Freund’s adjuvant (CFA) and Mycobacterium tuberculosis. (Luross and 
Williams, 2001) Using this model, effects of gene knockout can be studied in greater 
detail. It is also clinically relevant as collagen type II antibodies are present in patient 
samples and also reflect inflammatory activity measured by TNF-alpha and IL-6 levels 
in these individuals. (Cook et al., 1996; Kim et al., 2000) 
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1.4.2 Potential role for the PTEN/PI3K pathway in rheumatoid 
arthritis 
 
L-12, which is composed of p40 and p35 subunits seems to have an important role in 
the development and establishment of CIA and thus RA. (Joosten et al., 1997) IL12 is 
a cytokine that classically drives the Th1 type of inflammatory response, which is 
characterized by excessive IFN-gamma production. A consequence of this 
predominant Th1 response is massive tissue destruction as it is present in RA. 
IL-12 production has been shown to be suppressed by PI3K. Furthermore, production 
of Th2 cytokines, namely IL-4 and IL-5 has been shown to be reduced in PI3K 
knockout mice. (Fukao et al., 2002) Fukao et al. also state, that differentially regulated 
p38 in PI3K knockout cells might account for the different IL-12 levels. (Fukao et al., 
2002) In PTEN deficient cells, the opposite was observed, namely they produce less 
IL-12 and TNF, but more IL-10. (Kuroda et al., 2008) 
A Swiss group demonstrated that PI3K p110 gamma knockout mice are protected in 
animal models of rheumatoid arthritis. Also, a specific PI3K gamma inhibitor 
suppresses disease progression. They claim that the effect is caused by decreased 
neutrophil influx in the -/- mice. (Camps et al., 2005) 
Somewhat contradictory to their findings are the obervations made in the neutrophil 
specific (Ela2cre) PTEN knockout mouse which was found to be protected in a 
serum-transfer model of arthritis. They also demonstrate reduced neutrophil influx 
due to impaired chemotaxis in PTEN KO animals. (Heit et al., 2008)  
Another group investigated adenovirus-mediated PTEN transfer into rats and found 
amelioration of CIA symptoms. (Wang et al., 2008) 
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2. OBJECTIVES 
 
The aim of this thesis was to further elucidate the beneficial role of the PI3K-PTEN 
pathway in different experimental settings. In order to ensure relevance of this issue 
in vivo and not only in the cell culture dish, different animal models have been 
applied. 
PTEN has already been studied in various cancer-related contexts, but has only 
recently attracted the attention of immunologists. (Suzuki et al., 2001) It was shown to 
be important in neutrophil chemotaxis,(Heit et al., 2008) but also in limiting the 
cytokine release upon endotoxin challenge. (Luyendyk et al., 2008)  
Inflammation plays an important role in the pathology of atherosclerosis. (Glass and 
Witztum, 2001; Libby, 2002) An important process in atherogenesis is the influx of 
macrophages in the arterial intima and subsequent foam cell formation. As our PTEN 
deficient macrophages showed decreased inflammatory response in various 
experimental settings, we speculated that PTEN deficiency might also influence the 
outcome in an animal model of atherosclerosis. We thus used in vivo as well as in 
vitro methods to determine the outcome of macrophage specific PTEN knockout on 
atherosclerotic processes. 
 
Another animal model where an overwhelming inflammatory response is detrimental 
is the collagen-induced arthritis model for autoimmunity. In this context, Fukao et al. 
nicely demonstrated that disruption of the PI3K signalling pathway leads to enhanced 
IL-12 production and, as a consequence, a dominant Th1 driven immune response. 
(Fukao et al., 2002) As knockout of PTEN enhances PI3K dependent signalling, we 
speculated that in our animal model of rheumatoid arthritis, PTEN might play a 
beneficial role by limiting pro-inflammatory T helper cell responses. We thus used 
myeloid specific PTEN knockout mice to study the role of this gene in the interplay 
between innate and adaptive immunity. 
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3. MATERIALS AND METHODS 
 
3.1 Materials 
 
Lysis buffer (ready to use) for genotyping of mice contains:       
Tris-Cl 100mM (pH 8.0)   12.11g/100ml  
EDTA 5mM (pH 8.0)        18.61g/100ml  
SDS 0.2%                 20g/100ml  
NaCl 200mM                 11.69g/100ml  
 
TAE (50X) (Tris, Acetic Acid, EDTA) 
 900ml dH2O 
 242g Tris Base  
 57,1ml Glacial Acetic Acid  
 18,6 g EDTA  
 dH2O up to 1 liter 
 
PBS (10x) (Phosphate Buffered Saline) 
 800ml dH2O 
 80g NaCl 
 2.0g KCl 
 14,4g Na2HPO4 
 2,0g KH2PO4 
 adjust pH to 7,4 (with NaOH) 
 dH2O up to 1 liter 
 
PBST (Phosphate Buffered Saline Tween) 
 100ml PBS (10x) 
 5g Tween-20  
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dH2O up to 1 liter 
 
RPMI-1640 full medium contains: 
 RPMI-1640 (Invitrogen, Karlsruhe, D) 
 10% FBS (Invitrogen, Karlsruhe, D) 
1% PSF (100U/ml penicillin, 100g/ml streptomycin, 0.25g/ml amphotericin) 
(Invitrogen, Karlsruhe, D) 
 1% L-Glutamine (Invitrogen, Karlsruhe, D) 
 
 
3.2 Mice experiments 
 
3.2.1 Mice handling 
 
PTEN fl/fl mice were obtained by T.W. Mak (Suzuki et al., 2001), LysM cre transgenic 
mice were kindly provided by R. Johnson. (Peyssonnaux et al., 2005) ApoE 
transgenic mice were a kind gift of C.J. Binder. 
Mice were bred in the basement facility of our institute in compliance with Austrian 
laboratory animal law and institutional guidelines. The health status of our mice was 
regularly checked. 
A convenient surrounding for mice was provided by continuous ventilation, constant 
temperature (20-22°C) and a 12h day/night light-cyc le. Breeding cages usually 
consisted of 1 male and 2-3 females. Pups were weaned at 3-4 weeks of age 
according to sex and genotype. At approximately 5 weeks of age, mice were 
genotyped. 
Some mice were kept on a high fat diet (Western Diet; SNIFF, Soest, Germany) to 
enhance lesion formation in atherosclerotic mice. 
Experiments were always performed with age-matched littermate controls. All mice 
were backcrossed onto a C57BL/6 background for at least 6 generations. 
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3.2.2 Anaesthesia of mice 
For short time sedation, the inhalational anesthetic Forane® was used. Its huge 
advantage is that it does not interfere with inflammatory pathways and that it acts 
immediately and thus it is perfect for short procedures such as drawing blood. 
A mixture of Ketamine as a dissociative anesthetic and Xylazine as a powerful 
sedative/analgesic was used to anesthesize mice for longer periods of time. Usually 
we took 10% Ketaminol® and 5% Xylasol® diluted in sterile Ringer’s Solution and 
injected 10 times the bodyweight of a mouse (in µl) for up to two hours of anesthesia.  
 
3.2.3 Induction of collagen induced arthritis in mice 
 
According to materials and methods by Kai et al., 200µg of chicken type II collagen in 
0.05 M acetic acid together with an equal volume of complete Freund’s adjuvant 
(CFA) and heat-killed Mycobacterium tuberculosis were injected intradermally at the 
tail base of mice. (Kai et al., 2006) To ensure that effects are not caused by the 
adjuvant, a CFA-only control was used. A second injection (boost) was performed 3 
weeks later, and this day was designated as day 0.  
Mice were expected to develop severe hind paw arthritis 5 to 10 weeks after the 
second boost. Clinical scores of mice affected by arthritis were done on a regular 
basis. Mice were scored as described previously by assessing joint swelling and grip 
strength. (Redlich et al., 2002)  
 
Swelling was judged in all four paws by using a semi quantitative score:  
0  no swelling 
1  mild swelling of toes and ankle 
2 moderate swelling of toes and ankle 
3  severe swelling of toes and ankle 
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Grip was similarly assessed:  
0 normal grip strength 
–1  mildly reduced grip strength 
–2  severely reduced grip strength 
–3  no grip at all 
 
Both scores were then combined and are indicated as arthritis score. All assessments 
were performed in blinded fashion. 
Animals were killed 2 to 5 weeks after the boost. Histology of hind paws was 
performed by Birgit Niederreiter to visualize signs of arthritis such as cellular 
infiltrations, hyperplasia of synovial tissue and bone erosions. (Redlich et al., 2002) 
Histological TRAP stainings were then analysed by OsteoMeasure Analysis System 
(OsteoMetrics). 
Autoantibody levels were also kindly determined by members of the Division of 
Rheumatology, MUW. (Redlich et al., 2002) 
 
3.2.4 Genotyping mice 
 
3.2.4.1 Tissue preparation 
Mice were earmarked using an ear-tag punch (Fisher Scientific) according to the 
following scheme (Figure 3.2). Punched tissue or pieces of the tail were put into a 1.5 
Eppendorf tube.  
 
 
 
 
 
 
 
 
Figure 3.1: Scheme for earmarking of mice 
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To lyse cells, 95µL lysis buffer (Tris-Cl 100mM, EDTA, SDS 0.2%, NaCl 200mM) and 
5 µL Proteinase K 10mg/mL, recombinant, PCR Grade (Roche Diagnostics, 
Mannheim, D) were added to each tissue sample. After at least 3 hours incubation 
(55°C, 650rpm), Proteinase K was diluted using 1 mL  ddH2O. In a centrifugation step 
(5 min, RT, 13 krpm) unlysed tissue was pelleted. Proteinase K was then finally 
inactivated through heat (10 min, 99°C, 650 rpm). S amples were spinned down and 
cooled. 
 
Polymerase chain reaction 
For amplification of the isolated mouse DNA, Polymerase chain reaction (PCR) was 
performed using the following mastermix: 
 5 µL  5x buffer (containing 1.5 mM MgCl2) 
 2.5 µL  dNTPs (2 mM) 
 1µL  Primer (10 pm/µL each) 
 1 µL   DNA lysate 
 0.125 µL GoTaq™ DNA Polymerase (Promega, Madison, WI, USA, 5u/µL) 
 15.375 µL ddH2O 
 
Primers: 
ApoE 
ApoE forward 1:10 5’-GCC TAG CCG AGG GAG AGC CG-3’ 
ApoE revers 1:20 5’-TGT GAC TTG GGA GCT CTG CAG C-3’ 
ApoE revers mut 1:20 5’-GCC GCC CCG ACT GCA TCT-3’ 
 
PTEN  
PTEN forward 1:10 5’-CTC CTC TAC TCC ATT CTT CCC-3’ 
PTEN revers 1:10 5’-ACT CCC ACC AAT GAA CAA AC-3’ 
 
Cre  
Cre forward 1:10 5’-TCG CGA TTA TCT TCT ATA TCT TCA G-3’ 
Cre revers 1:10 5’-GCT CGA CCA GTT TAG TTA CCC-3’ 
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PCR programs: 
 
PTEN / Cre 
94° 3:00    
94° 0:45    
60° 0:45      35x 
72° 1:00 
72° 5:00 
15° 4ever 
Expected bands:  WT (PTEN) band: 228bp  
KO (floxed) band: 335bp 
   Cre band: 500bp 
 
ApoE 
94° 3:00    
94° 0:20    
68° 0:40      30x  
72° 2:00 
72° 5:00 
15° 4ever 
Expected bands:  WT band: 155bp 
KO band: 245bp 
 
PCR samples were applied on a 2% Agarose gel (5g Agarose in 250 mL 1x TAE-
buffer) containing EtBr (1:10000). 
 
3.2.5 Collection of blood 
 
Blood was either collected from the inferior vena cava or from the retroorbital sinus of 
anesthetized mice. Blood was mixed with sodium citrate (3.2% wt/vol) at a ratio of 
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10:1. To obtain plasma samples, whole blood was centrifuged (10min, 8 krpm) and 
the supernatant in different dilutions could be used for ELISA analysis. 
 
3.3 In vitro experiments 
 
3.3.1 Isolation of peritoneal macrophages 
 
2mL of Thioglycollate (4% in dH2O) were injected peritoneally to elicit the recruitment 
of macrophages into the peritoneum. After 3 days, mice were anesthetized with 
approximately 10x bodyweight (in µL) of a solution containing Ketamine and Xylazine. 
A peritoneal lavage was performed with 5 mL of RPMI -1640 media to obtain 
thioglycollate elicited macrophages. The cells were then centrifuged (5’, 1500rpm) 
and diluted in RPMI containing 10% Fetal Calf Serum, glutamine and antibiotics for a 
final concentration of 10^6 cells per mL. 
 
3.3.2 Isolation of bone marrow and differentiation of dendritic cells 
 
Mice were sacrificed either on dry ice or through cervical dislocation. Skin and 
muscles were removed from the long bones of the hind paws. Femur and tibia were 
flushed with pure RPMI-1640 medium to obtain murine bone marrow which then 
could be used to differentiate BM-derived dendritic cells.  
Dendritic cells were generated using RPMI full medium containing 10 to 15 µg/mL 
GM-CSF. After 7-9 days, cells in the supernatant were harvested and plated to use in 
experiments. 
BM-derived DCs were then analyzed by Stefan Blüml using standard FACS 
procedures to ensure proper differentiation. 
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3.3.3 Stimulation of macrophages 
 
Cells with a concentration of 106 /mL were plated on 12 well dishes. After 
approximately 2 hours incubation, the incubation medium was changed to remove 
non-adhering cells. On the following day, stimuli were added in the following final 
concentrations: 
LPS (Invitrogen Corp., Carlsbad, CA, USA): 1µg/mL 
OxLDL (see protocol for oxidation of LDL): 50µg/mL  
CpG: (Invivogen Corp., Carlsbad, CA, USA): 1-5 µM 
oxPAPC (see protocol for OxPL use): 20µg/mL 
 
3.3.4 Staining of foam cells using Oil Red O 
 
Medium was removed from the cells and fixative (IHC zinc fixative, BD) was added to 
the cells for at least 15 minutes at room temperature. After removing the fixative, the 
wells were washed once with 60% isopropanol. Then Oil Red O working solution (see 
instructions) was added to the dry wells. After 10 minutes, Oil Red O was removed 
and the wells were washed 5 times under running tap water. 
In order to elute Oil Red O, cells were washed with 30% isopropanol and then the 
stain was eluted with 100% isopropanol. Flourescence could be measured in a Bio-
Tek EL808 Ultra Microplate Reader (Bio-Tek Instruments, Winooski, VT, USA) at 
500nm. To counterstain the nuclei, cells were incubated with hematoxylin for 10 
seconds and washed again with water. 
 
3.3.5 Oxidation of LDL 
 
After determination of protein concentration using Bradford assay, LDL (kindly 
provided by V. Botchkov) was dialyzed against 3 litres of PBS at 4°C. After 6 to 8 
hours, the buffer was changed and dialysis continued overnight. On the next day, 
possible volume changes were noted and a small aliquot was taken as unoxidized 
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control. This aliquot was mixed with 0,01% BHT (butylated hydroxytoluene) and 200 
µM EDTA to avoid further oxidation. Remaining dialysed LDL was oxidized overnight 
at 37°C by adding 10mM CuSO4 to a final concentrati on of 10 µM. As a control for 
the oxidation process, conjugated dienes of oxidized and native LDL were measured 
by determining the optical density of a 20 µg/ml dilution at 235 nm. 
200 µM EDTA was then added to the oxidized LDL and further dialysis at 4°C 
overnight against 3 litres of PBS including 200 µM EDTA was done to stop the 
oxidation process. To remove precipitated proteins for long time storage, oxLDL was 
then centrifuged at 500 rpm for 20 min at 4°C. To a ssure purity, oxLDL was then 
sterile filtered (0,2 µm filter). To determine the exact protein concentration, a common 
used Bradford was performed. 
This oxidation was performed according to (Wang et al., 2008) and (Uda et al., 2006). 
 
3.3.6 Preparation of oxidized phospholipids for use in cell culture 
 
Phospholipids dissolved in chloroform (10 mg/mL) and stored at -80°C were kindly 
provided by Olga Oskolkova. Phospholipid suspensions were prepared freshly for 
each experiment. Phospholipids were transferred into Falcon tubes and chloroform 
was evaporated under a stream of argon. Dried phospholipids were resuspended in 
prewarmed RPMI-1640 full (37°C) by vortexing at max imal speed for 30 seconds, 
incubating for 5 min at 37°C and again vortexing fo r 1 min. 
 
3.4 Isolation and staining of mouse aorta 
 
3.4.1 Isolation 
 
Mice were sacrificed on dry ice to prevent vascular damage of larger vessels. Blood 
was drawn from vena cava (heparinised 1mL syringe, 27G needle). Then, the vena 
cava was cut to allow perfusion with 10-20mL of 1x PBS to remove blood. To fix 
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tissue and plaques, the aorta was then perfused with 4% PFA in PBS. Then, organs, 
except for heart and kidney could be removed. Finally the aorta was dissected. Fat 
and the adventitia were removed to allow better staining. Then the aorta was opened 
longitudinally. During this procedure, the aorta and the heart / kidneys were still 
associated. After incubating the aorta in fixative for 3 days, they it could be pinned 
onto a black wax dissection pan. 
 
3.4.2 Staining of aorta 
 
Pinned aortas were incubated in 0.5% Sudan IV solution in 70% ethanol/acetone 
(1:1) for 15 minutes. Sudan IV was removed and 80% ethanol was added to the 
aortas 2-5 minutes until normal aortic regions containing no plaques appeared white. 
Ethanol was removed by washing the aortas 15 minutes under running tap water. 
Pictures were taken to allow quantification by Image J. 
 
3.5 Analysis methods 
 
3.5.2 ELISA enzyme-linked immunosorbent assay - Measurement of 
Cytokines/Chemokines 
 
Blood samples (0.1 mL) were collected from the retro-orbital sinus. Plasma 
concentrations of TNF-alpha, IL-6, IL-10, E-selectin were measured using commercial 
DuoSet ELISA kits (R&D Systems, Minneapolis, MN, USA).  
 
3.6.2 Real-Time Polymerase Chain Reaction 
 
Total RNA was isolated from lysed cells using 0.8 mL of Trizol (Invitrogen). Samples 
were then used to synthesize cDNA using the SuperScript First-Strand Synthesis kit 
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(Invitrogen). To quantitate the levels of the desired mRNA, PCR primers were used at 
a final concentration of 900 nM and the probe at a final concentration of 900 ng per 
reaction under standard thermocycling conditions using a Fast SYBR Green 
Mastermix (Applied Biosystems, Foster City, CA, USA) and StepOne Real-Time PCR 
System (Applied Biosystems, Foster City, CA, USA). The melting curve was analysed 
after all SYBR runs to ensure that only a single PCR product is formed. Samples 
were normalized to levels of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
mRNA. Sequences of used primers are summed up in table 3.1 
 
Gene Forward primer (5’-3’) Reverse primer (5’-3’) 
GAPDH GGTCGTATTGGGCGCCTGGTCACC CACACCCATGACGAACATGGGGGC 
IL-6 TGCAAGTGCATCATCGTTGTTC CCACGGCCTTCCCTACTTCA 
IL-10 TGGCCCAGAAATCAAGGAGC CAGCAGACTCAATACACACT 
PTEN ACACCGCCAAATTTAACTGC TACACCAGTCCGTCCCTTTC 
IL12p40 ACAGCACCAGCTTC-TTCATCAG CCTCACCCTCGGCATCCAGCAGC 
IL12p35 CCAAGGTCAGCGTTCCAACA AGAGGAGGTAGCGTGATTGACA 
IL23p19 TGGCTGTGCCTAGGAGTAGCA TTCATCCTCTTCTTCTCTTAGTAGATTCATA 
CD36 GGAGCAACTGGTGGATGGTT TTGAGACTCTGAAAGGATCAGCA 
SR-A3 GCTTCAGAAGATGCTGCTAGCC TGACTGCTTCTGGTGGAGAGC 
SR-B1 ACGGCCAGAAGCCAGTAGTC CGGTGTCGTTGTCATTGAAG 
SR-B2 GGTGTTGAACATCAGCATCTGC AACGAACTTCTCGTCGGCTTG 
CD36 GGAGCAACTGGTGGATGGTT TTGAGACTCTGAAAGGATCAGCA 
CD68 TGGCGCAGAATTCATCTCTTC GGTCAAGGTGAACAGCTGGAG 
MARCO TGATGCGACTGTCTTCTGTCG CATTGTCCAGCCAGATGTTCC 
SR-A3 GCTTCAGAAGATGCTGCTAGCC TGACTGCTTCTGGTGGAGAGC 
SR-B1 ACGGCCAGAAGCCAGTAGTC CGGTGTCGTTGTCATTGAAG 
SR-B2 GGTGTTGAACATCAGCATCTGC AACGAACTTCTCGTCGGCTTG 
 
Table 3.1: Oligonucleotides for cDNAs analysis by semi quantitative real-time PCR 
 
3.6.3 Western Blotting 
For visualization of different proteins on Western blot, stimulated macrophages were 
harvested and lysed in Laemmli buffer, denatured (96°C, 10min) and separated by 
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SDS-PAGE (10%). Proteins were then blotted to a polyvinylidene fluoride membrane 
(Immobilion PVDF Transfer Membrane; Millipore, Bedford, MA, USA), blocked in 5% 
milk in PBST for at least 20 min, probed overnight with primary antibody, then washed 
3 times with PBST and incubated with horseradish peroxidase-coupled secondary 
antibody (GE Healthcare UK Limited, Buckinhamshire, GB) for at least 2 hours. 
Membranes were developed using the chemiluminescence reagent assay 
SuperSignal® West Femto (Pierce Biotechnology, Rockford, IL, USA) and exposed in 
chemiluminescence-imager FluorChem HD2. 
For normalization, membranes were incubated in stripping buffer for 30 min at 37°C, 
washed 3 times with PBST and then reprobing was performed as described earlier. 
 
Primary antibodies used (all Cell Signaling Technology, Beverly, MA) 
• PTEN 
• phospho-ERK 
• ERK 
• p38 
• phospho p38  
• Actin 
• pGSK3 beta (Ser9) 
• phospho-Akt (Thr308)  
 
Statistical analysis 
 
Data are given as mean ± standard deviation. Values were compared by using the 
unpaired two-tailed Student's t test. Significance is indicated by  (p<0.05). Statistical 
analysis was performed using Microsoft Excel and GraphPad Prism. 
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4. RESULTS 
 
4.1 PTEN in Atherosclerosis 
 
4.1.1 Knockout of PTEN in LysMcre macrophages was shown on protein 
as well as mRNA level 
 
Mice were routinely checked for their genotypes using earmarks or pieces of the tail. 
Standard PCR was performed on the cre and on the floxed allele. A representative 
genotyping picture is depicted in figure 4.1.A 
We also wanted to investigate whether the floxed allele is actually excised in 
macrophages. Thus thioglycollate-elicited macrophages were harvested from 
LysMcre positive or negative fl/flPTEN mice and 27 cycles of the same PCR protocol 
as used above revealed that the floxed band disappeared in LysMcre positive 
samples while the cre-band was still present. (Figure 4.1.B) 
Also real-time PCR performed on the same samples showed highly significant 
downregulation of PTEN mRNA. (Figure 4.1.C) 
On protein level, determined by Western blot analysis, it was even more obvious that 
PTEN is almost completely absent. (Figure 4.1.D) 
To allow atherosclerosis research, mice were crossed into an ApoE -/- background. A 
representative picture showing +/-, +/+ and -/- is shown in figure 4.1.E. For correct 
atherosclerosis studies, only ApoE -/- animals were taken into consideration. 
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Figure 4.1: PTEN is efficiently deleted in LysMcre PTEN fl/fl on DNA, mRNA and Protein 
level. (A) Pieces of mouse tissue were subjected to genotypic analysis. (B) PTEN alleles 
are successfully excised in PTEN -/-macrophages which are positive for LysMcre 
recombinase. (C) PTEN mRNA expression normalized to GAPDH is significantly reduced in 
LysMcre PTEN fl/fl thioglycollate-elicited macrophages. (D) PTEN protein is absent in 
Western blots of PTEN -/- peritoneal macrophages. (E)  Representative picture of 
routinely performed ApoE genotyping. Only ApoE -/- animals were used for in vivo 
atherosclerosis studies. 
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4.1.2 PTEN deficiency in macrophages results in enhanced intracellular 
levels of modified lipoprotein particles and enhanced foam cell formation
  
Thioglycollate-elicited macrophages from LysMcre flPTEN ApoE double deficient 
mice were isolated and plated. After fixation, they were stained with Oil Red O and 
Hematoxylin as a counterstain. A microscopic picture of stained foam cells was taken 
(Figure 4.2.A) and the number of positive stained cells per field was counted (Figure 
4.2.B, right graph). A tendency to more positively stained foam cells in PTEN 
knockouts was visible.  
Additionally, an essay for in vitro foam cell formation was used. Thioglycollate-elicited 
macrophages from LysMcre fl/fl PTEN mice were incubated with or without oxLDL 
o/n. Lipid-loaden foam cells were stained with the method previously described. 
Figure 4.2.C confirms the data obtained with in vivo generated foam cells by showing 
more staining in PTEN -/- wells. Counterstain was performed using hematoxylin to 
ensure that equal cell numbers were used. (Data not shown)  
Figure 4.2.B (left graph) shows the optical density of Oil Red O eluted by Isopropanol 
and measured in an ELISA plate reader in in vitro generated foam cells. 
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Figure 4.2: Foam cell formation in LysMcre PTEN fl/fl mice (A) Microscopic picture of lipid laden foam 
cells, isolated from ApoE -/- PTEN KO and WT mice. (B) Quantification of in vitro generated foam cells 
by Oil Red O elution (left) and percentage of positively stained in vivo generated foam cells per 
microscopic field. (n = 3 mice per group). (C) Macroscopic picture of wells with in vitro generated foam 
cells staine with Oil Red O. 
  45 
4.1.3 Effects of PTEN knockout in macrophages in atherosclerosis 
associated signalling 
 
Thioglycollate-elicited macrophages of PTEN -/- and +/+ mice were stimulated with 
oxidized low-density-lipoprotein (oxLDL) or Oxidized-1-palmitoyl-2-arachidonyl-sn-
glycerol-3-phosphocholine (oxPAPC) over night. Cells were harvested in SDS-PAGE 
sample buffer and subjected to Western blot analysis. Incubation with phospho AKT 
antibody in comparison to total AKT revealed that PI3K dependent phosphoylation of 
AKT is induced by oxLDL and oxPAPC. (Figure 4.3.A) 
One of the hypotheses we wanted to test was, whether expression of scavenger 
expression is different in PTEN knockout macrophages. We thus took thioglycollate-
elicited macrophages from LysMcre PTEN fl/fl mice and WT control mice and isolated 
RNA. Real time PCR nicely demonstrated that expression of scavenger receptors 
SR-AIII, CD36, SR-BI, CD68, SR-BII in PTEN deficient macrophages does not differ 
from wildtype controls. (Figure 4.3.B) Therefore we concluded that differential SR 
expression is not responsible for enhanced foam cell formation. 
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Figure 4.3: Activation of PI3K signaling by oxLDL and oxPAPC and comparison of scavenger receptor 
expression in unstimulated PTEN deficient peritoneal macrophages (A) Enhanced levels of phospho-
AKT compared to total AKT levels upon stimulation of WT macrophages with oxLDL or oxPAPC o/n. 
(B) Enhanced foam cell formation of PTEN deficient peritoneal macrophages is not caused by 
differential expression of scavenger receptors SR-AIII, CD36, SR-BI, CD68, SR-BII and MARCO (n=4 
mice per group). Target genes were normalized to GAPDH, results are not efficiency corrected.  
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4.1.4 Analysis of atherosclerotic plaques in en face preparations of aortas 
of LysMcre flPTEN mice  
 
LysMcre fl/fl PTEN mice were kept on a normal diet for 16 weeks after birth and then 
sacrificed on dry ice. Weight was determined and aortae of mice were harvested and 
stained with Sudan IV. A representative picture of stained aortae pinned on a black 
wax dissection pan is shown in figure 4.4.A. Red stained lesion areas were quantified 
by ImageJ and are given as percentage of total aortic area. Group 1 (Figure 4.4.B) 
gives the result of 12 mice, shown separately for males and females. Only in males a 
difference between WT and KO could be shown. Fitting to the data on foam cell 
formation, lesion area in PTEN -/- mice was enhanced. 
To allow better statistics, a second group (10 mice) was analysed. To our surprise, 
this time WT mice had more stained areas than compared to KO. (Figure 4.4.C) 
Overall, the analysis of aortic plaques did not give us statistically significant results. 
The main reason might be that the mice were still too young and should have been 
kept on an additional high fat diet to see more effects. The conclusion was to analyse 
mice aged 24 weeks or older because there the lesion area will be at least above 1% 
and we also expect genotype differences to be enhanced. 
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Figure 4.4: Analysis of atherosclerotic plaques in ApoE -/- LysMcre PTEN fl/fl mice. (A) 
Representative picture of en face preparations of ApoE -/- PTEN WT and KO murine aortae. In these 
animals, which were part of the first group analysed, the difference is mainly in the abdominal section. 
Quantification of lesion area of group 1 (n=12) (B), and group 2 (n=10) (C) with ImageJ analysis 
software, separated by gender and genotype. 
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4.2 PTEN in Rheumatoid Arthritis 
 
4.2.1 Mice deficient for PTEN in myeloid cells show significantly 
decreased symptoms for arthritis than wildtype control mice 
 
CIA was induced in LysMcre PTEN fl/fl (PTEN KO) mice using type II collagen and 
CFA containing M. tuberculosis as described in the material and methods section.  
Clinical score was assessed weekly and 2 weeks after the second boost, first 
symptoms were visible in the wildtype control mice. At this time point, no significant 
joint arthritis could be detected in PTEN KO mice, whereas WT mice were already 
affected. (Figure 4.5.A and C) In a time course until 6 weeks after boost, this effect 
persisted. KO mice only developed mild arthritis in comparison to CFA-control, but in 
wildtype mice disease severity as indicated by arthritis score increased. (Figure 4.5.A) 
Figure 4.5.B shows the phenotype of PTEN WT and KO hind paws, which are mostly 
affected in this model of CIA because they are closest to the tail base where collagen 
is injected. 
Histology was then performed by Birgit Niederreiter on synovial joints of KO and WT 
control mice to distinguish inflamed pathological tissue from the respective normal 
one. (Figure 4.5.D) Using a TRAP stain and the analysis software OsteoMeasure, 
detailed comparison of different parameters of histological sections was possible. 
What we found is that joint inflammation and bone erosion in KO tissue samples was 
significantly reduced in comparison to wild-type mice and almost resembled the CFA-
control. (Figure 4.8.D) 
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Figure 4.5: Symptoms for arthritis are reduced in LysMcre PTEN fl/fl mice. (A) Significant lower 
arthritis score in PTEN -/- mice. (B) Phenotype of arthritis affected hind paws of 2 representative PTEN 
WT and KO pairs. (C) Arthritis score dot plot of CIA-mice hind paws, 2 weeks after the second boost. 
(D) Histology of synovial joints of CIA-mice hind paws. (OsteoMeasure analysis depicted in Fig. 4.7.D) 
Arthritis score includes swelling and grip strength. 
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4.2.2 Reduction of inflammatory markers in plasmas of PTEN KO CIA 
mice but no effect on collagen autoantibodies level 
 
Blood samples of PTEN WT and KO mice at day 0 and 3, 4 and 5 weeks after CIA 
boost were collected. (See scheme in figure 4.6) Plasma levels of IL-6, KC and 
soluble E-selectin were measured by ELISA. Consistent with previous data obtained 
by our group and others, levels of different proinflammatory cytokines were reduced 
in PTEN KO mice. Only 5 weeks upon challenge, protein levels of IL-6 and KC were 
similar, so one can assume that the effect of PTEN is already present in early 
arthritis. (Figure 4.7.A, B and C) 
Autoantibody levels to type II collagen in plasma samples were also measured to 
check if different antibody titers might correspond with the effect seen in vivo. 
Surprisingly only 3 weeks after the second boost, antibody levels were slightly 
decreased in PTEN knockout mice subjected to CIA, but at all the other timepoints, 
no significant difference could be detected. (Figure 4.7.D) 
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Figure 4.6: Scheme for Collagen-induced arthritis: Blood was collected 0, 3, 4 and 5 weeks after the 
first collagen challenge. 5 weeks after CIA induction, histology samples were collected. 
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Figure 4.7: Reduced proinflammatory cytokines, but similar autoantibody levels in PTEN -/- CIA mice. 
(A, B and C) Levels of IL-6, KC and soluble E-selectin in plasmas of arthritic mice, determined by 
ELISA. (D) Anti-Chicken IgG in arthritic mice, ELISA. 
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4.2.3 Generation of bone-marrow derived dendritic cells which showed 
the expected PTEN knockout phenotype 
 
To test the hypothesis whether the Lysozyme M specific knockout of PTEN also 
affects other cells of the myeloid lineage different from macrophages, bone marrow 
(BM) of LysMcre fl/fl PTEN mice was isolated and differentiated with GM-CSF to 
obtain in vitro generated BM-derived dendritic cells (DCs). These cells are usually 
non-adherent and were thus isolated from the supernatant. In order to see a potential 
PTEN knockout in DCs, samples for RNA and protein analysis were taken. Another 
aliquot of the cells was taken to check for expression of DC-specific surface markers 
in FACS analysis.  
Real-time PCR results nicely demonstrated that PTEN mRNA levels are significantly 
reduced in LysMcre + fl/flPTEN dendritic cells. (Figure 4.8.A) The remaining 10% of 
PTEN mRNA might be due to contamination by other, non-myeloid cells such as 
fibroblasts or B-cells.  
DCs harvested in Laemmli sample buffer were applied on a SDS-polyacrylamid-gel. 
Western blots were developed for total AKT, phospho-AKT (Thr 308) and phospho-
GSK3beta (Ser9). As expected, levels of phospho-AKT, which is the most important 
downstream signalling component of the PI3K/PTEN pathway, were enhanced in 
PTEN -/- cells whereas total AKT levels are equal in WT and KO samples. 
Additionally, pGSK3beta as the probably most important downstream target of 
AKT/PKB is also enhanced in PTEN -/- cells. (Figure 4.8.B) 
Analysis of BM-derived DCs in flow cytometry revealed equal expression of surface 
markers in WT and KO cells. Furthermore, correct differentiation into DCs was 
confirmed by measuring mean fluorescence intensity of CD80, CD86 and CD40. 
(Figure 4.8.C) 
Also in LPS-stimulated DCs 2, 4 and 6 hours after stimulation, the knockout effect on 
PTEN was present. (Figure 4.8.D) 
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Figure 4.8: Generation of DC containing the expected PTEN KO phenotype was confirmed. (A) PTEN 
mRNA measured in real-time PCR is markedly reduced in LysMcre PTEN fl/fl mice. (B) Levels of 
phospho-AKT and phospho-GSK3beta are enhanced due to hyperactive PI3K signalling. (C) Flow 
cytometry data on PTEN WT and KO dendritic cells. (D) Also in LPS stimulated cells, PTEN mRNA is 
reduced in KO dendritic cells. (E and F) Quantification of joint inflammation and bone erosion for 
histologic pictures as depicted in figure 4.5.D. 
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4.2.4 Inflammatory cytokines are reduced in in vitro generated BM-
derived PTEN -/- dendritic cells  
 
Dendritic cells were differentiated out of bone marrow as described previously. 
Thereafter, they were stimulated with different PAMPs o/n and samples for RNA and 
ELISA analysis were prepared. 
Figure 4.9.A shows effects of LPS, PGN and the Triacyl-lipopeptide Pam3Cys on 
induction of IL-6 and IL-10 mRNA induction. Pam3Cys, which stimulates TLR-2 
shows the smallest effects on mRNA induction. The effects of peptidoglycan and 
lipopolysaccharide are more pronounced. In these samples a clear difference 
between WT and KO can be seen. As already demonstrated in macrophages, KO of 
PTEN in DCs also leads to downregulation of proinflammatory IL-6 mRNA.  
Contrary to this is the finding that IL-10, which is assumed to be anti-inflammatory, is 
reduced in KO samples, but it was shown in several independent experiments. 
Interestingly, macrophages show the opposite effect, namely upregulation of IL-10 in 
the PTEN -/- cells. 
Additionally, protein levels in supernatants of LPS, PGN, Pam3Cys and CpG DNA 
stimulated PTEN +/+ and -/- cells were measured by ELISA. These effects further 
supported the data obtained by real-time PCR. IL-6 as well as IL-10 protein levels 
were always profoundly reduced in KO in comparison to WT. 
Figure 4.9.B depicts a timecourse of IL-6 and IL-10 mRNA induction upon LPS 
challenge. Not only after o/n stimulation, but also 2, 4 and 6 hours after stimulation 
the above mentioned effect was present. IL-6 and IL-10 levels were always reduced 
in KO samples, even though the reduction was not always statistically significant.  
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Figure 4.9: Reduced inflammatory cytokine production in PTEN -/- BM-derived DCs. (A) IL-6 and IL-10 
mRNA measured in real-time PCR is reduced in LysMcre PTEN fl/fl mice, stimulated with LPS, PGN 
and Pam3Cys (left panels). Also, IL-6 and IL-10 protein levels go in line with the data obtained on 
mRNA level (right panels) (B) IL-6 and IL-10 mRNA levels 2, 4 and 6 hours after LPS stimulation are 
reduced in PTEN KO BM-derived DCs. 
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4.2.5 Reduced levels of all subunits of IL-12 may account for the anti-
inflammatory effect of the PTEN knockout 
 
In vitro generated BM-derived dendritic cells were stimulated with LPS for 2, 4 and 6 
hours. RNA was isolated of the respective samples and real-time PCR was 
performed. Figure 4.10 depicts the outcome on mRNA induction of IL-12 subunits. It 
could be demonstrated, that all IL-12 subunits were reduced in PTEN -/- cells in 
comparison to wt. The p19 subunit, which forms active IL-12 together with p40, shows 
the most prominent reduction. (Figure 4.10.A) Subunit p35, a component of IL-23, is 
also markedly reduced in PTEN KO. (Figure 4.10.B) Surprisingly, also subunit p40, 
which was previously assumed not to be affected by PTEN, was slightly 
downregulated. (Figure 4.10.C) 
These results perfectly fit to the data obtained by Fukao et al. which showed the 
opposite effect in PI3K knockout cells. (Fukao et al., 2002) 
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Figure 4.10: Subunits of IL-12 and IL-23 less abundant in PTEN KO BM-derived DCs. (A) IL-23 
subunit p19, (B) IL-12 and IL-23 common subunit p40 and (C) IL-12 subunit p35 are reduced on mRNA 
level 2, 4 and 6 hours after LPS stimulation.  
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4.2.6 Differential regulation of MAPK signalling might account for the 
downregulatory effects on cytokine levels by enhanced PI3K signalling 
 
MAPK signalling plays an essential role in the regulation of cytokine production in 
inflammatory conditions. We wanted to test the hypothesis whether enhanced levels 
of PIP3 as present in our PTEN KO DCs influence phosphoylation of MAPK and thus 
account for the reduced cytokine production. 
Thus in vitro differentiated BM-derived DCs were stimulated with LPS for 10, 20 and 
30 minutes. Samples were harvested in Laemmli buffer and then subjected to 
Western blot analysis. Development with phospho-ERK1/2 antibody revealed that 
levels of phosphoylated protein are reduced in PTEN -/- DCs whereas total ERK1/2 
levels did not differ. (Figure 4.11.A) Normalization to Actin confirmed loading of equal 
amounts of protein.  
As expected, levels of phospho-GSK3beta were enhanced in PTEN KO due to 
excessive PI3K signalling. Only slight changes in GSK3beta phosphoylation upon 
LPS stimulation can be seen (Figure 4.11.A)  
Even more important, reduced p38 MAPK phosphoylation was found in BM-derived 
PTEN deficient DCs upon stimulation with CpG DNA or LPS. (Figure 4.11.B) 
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Figure 4.11: Reduced phosphoylation of MAPK p38 and ERK1/2 in PTEN -/- DCs. (A) Western blot of 
BM-derived DCs stimulated with LPS for 10, 20 and 30 minutes with phospho ERK1/2, total ERK, 
phospho GSK3beta and Actin. (B) Phospho p38 and total p38 Western blot of PTEN WT and KO BM-
DCs stimulated with LPS and CpG. 
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4.3 Manuscripts in preparation 
 
4.3.1 Myeloid PTEN enhances inflammation but impairs bactericidal 
activities during murine pneumococcal pneumonia  
 
Gernot Schabbauer, Ulrich Matt, Philipp Günzl, Tanja Furtner, Eva Hainzl, Ildiko 
Mesteri, Bianca Doninger, Bernd R. Binder, Sylvia Knapp 
 
Manuscript submitted for publication in Journal of Immunology in May 2009 
 
 
 
4.3.2 Anti-inflammatory properties of the PI3K pathway are mediated by 
IL10/DUSP regulation 
 
Philipp Günzl, Eva Hainzl, Ulrich Matt, Barbara Dillinger, Benedikt Mahr, Sylvia 
Knapp, Bernd R. Binder, Gernot Schabbauer 
 
Manuscript in preparation, will be submitted to European Journal of Immunology in 
May 2009 
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5. DISCUSSION 
 
In this diploma thesis, genetically modified mice were used to dissect the PI3K/PTEN 
pathway in different animal models of human diseases. Our group focuses mainly on 
anti-inflammatory properties PI3K as described already by Luyendyk and others. 
(Luyendyk et al., 2008) We therefore utilised two different animal models of chronic 
inflammation. In rheumatoid arthritis, which is mainly an autoimmune disease, 
excessive immune activation is detrimental. Peter Libby has recently reviewed the 
common link between RA and atherosclerosis, which is expression of 
proinflammatory cytokines such as IL-1, IL-6 and TNF-alpha. (Libby, 2008) 
 
5.1 Atherosclerosis 
 
Formation of atherosclerotic plaques in mice as well as in humans is nowadays seen 
as a process of chronic inflammation. By knocking out genes for important 
inflammatory mediators such as MCP-1 or VCAM-1, mice are protected from 
atherosclerosis. In this thesis, I evaluated a possible effect of the PTEN gene, which 
has already been described as a regulator of inflammatory processes, in the 
formation of foam cells and atherosclerotic plaques. 
It could be shown in vitro as well as in vivo, that in PTEN fl/fl LysMcre+ mice, the 
PTEN gene expression shown on mRNA level is markedly reduced. Proper excision 
of the PTEN fl allele was observed in semi-quantitative PCR. On protein level, PTEN 
cannot be detected in significant amounts in LysMcre+ cells. 
To assess the effects of PTEN on foam cell formation, the first step was to get a clue 
whether PTEN KO enhances or reduces accumulation of intracellular lipids in 
comparison to wildtype control. I found increased lipid accumulation on microscopic 
as well as macroscopic scale in in vivo as well as in vitro generated foam cells 
stained by Oil Red O. 
We then hypothesized, that this effect might be due to differential expression of 
scavenger receptors, which are described as being important in lipid uptake by 
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macrophages. To our surprise, SR expression was not significantly different in PTEN 
KO cells, so this factor can be excluded. 
Indicating a role for the PI3K/PTEN pathway in atherosclerotic processes is the fact, 
that treatment of cells with oxLDL and oxPAPC increases AKT phosphoylation, which 
is the most important mediator downstream of PI3K. Additionally supporting our view 
that PI3K signalling plays a role in atherogenesis is the finding, that minimally 
modified LDL activated PI3K as well as Akt and led to phosphoylation of extracellular 
signal-regulated kinase ½ (ERK1/2).(Miller et al., 2005) 
 
A parallel approach was the analysis of in vivo effects on atherosclerotic plaque 
formation. For this purpose, PTEN fl/fl LysMcre+ were backcrossed onto an ApoE 
deficient background and analyzed for aortic lesion areas. So far, no precise 
conclusion can be drawn on basis of the data presented in this thesis. In the first 
group analysed, a tendency to more lesion formation was present, whereas in the 
second group, the opposite was the case. We assumed, that the reason for the large 
variation in the actual numbers was that the lesion area of mice was generally less 
than 1%, which is far too less to allow adequate analysis.  
The future plan is to isolate aortas of mice aged 24 weeks or older which are 
expected to develop more advanced lesions. Additionally, further data on mRNA 
induction upon oxLDL stimulation has to be collected to evaluate possible changes in 
gene expression in PTEN knockout mice that are relevant in atherosclerotic 
processes. 
Another approach to study PTEN function in atherosclerosis is the use of inducible 
conditional cre recombinase systems. As we failed to induce sufficient knockout in the 
tamoxifen-inducible estrogen-receptor cre mouse (Zhang et al., 1996), we are 
currently crossing PTEN fl/fl mice to a Mx-cre mouse, which is inducible upon polyI-
polyC injection. (Kuhn et al., 1995) Using this system, we try to address other cells 
important in atherosclerosis, such as endothelial cells. 
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5.2 Arthritis 
 
Autoimmune diseases such as rheumatoid arthritis are largely caused by excessive 
immune activation and reduced anti-inflammatory signals. RA is characterized by an 
infiltration of the synovia of multiple joints by inflammatory cells such as 
monocytes/macrophages, neutrophils and B-cells. Heit et al. already demonstrated a 
role for neutrophil specific (Ela2cre) knockout of PTEN in a K/BxN serum-transfer 
model of arthritis. (Heit et al., 2008) In this model, joint inflammation and degree of 
hindpaw swelling in Ela2cre PTEN fl/fl mice were significantly lower than in littermate 
control mice. They argue that differential neutrophil chemotaxis is primarily 
responsible for this effect. Nevertheless, it was demonstrated by Camps et al. that 
mice deficient in the class 1B PI3K subunit p110 gamma, which is responsible for 
transduction of G-protein coupled receptors, neutrophil infiltrates are reduced 
compared to wildtype. (Camps et al., 2005) 
As a starting point for studying RA in PTENfl/flLysMcre+ mice, we hypothesised that 
the anti-inflammatory properties of a hyperactive PI3K signalling axis, which were 
already described by our group and others in various projects, (Luyendyk et al., 2008; 
Yu et al., 2006) might also play a role in the pathogenesis of the disease. Cytokines 
are important in coordinating immune responses to resolve pathogenic infections, but 
play a detrimental role if their production is dysregulated. Thus, we focussed on 
differences in cytokine production and subsequent physiological consequences in CIA 
mice. 
 
In first in vivo studies, a clear protective effect in knockout mice of the PTEN gene in 
comparison to wt littermate control mice subjected to CIA could be observed. PTEN -
/- mice showed significantly decreased paw swelling and grip strength scores, but 
similar anti-collagen II antibody titers. These data indicate that reduced anti-collagen 
response through impaired dendritic cell migration may not play an important role, 
(Del Prete et al., 2004) because activation of antigen-specific B-cells takes place.  
We then decided to do histology on synovial joints of arthritic mice to get a clearer 
picture of the actual disease region. Evaluation of TRAP stains revealed significant 
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decrease in joint erosion and inflammation in PTEN -/- synovial joints which goes in 
line with the above described arthritic score. 
To evaluate whether the signs of this local inflammation are also present on a 
systemic level, pro-inflammatory cytokine production was measured in murine blood 
after CIA induction. IL-6, KC and E-selectin were found to be profoundly reduced in 
PTEN KO plasmas. To confirm this in vivo effect on a cell-based in vitro system, bone 
marrow-derived dendritic cells were stimulated with PAMPs and again, similar 
differences in cytokine levels were detected. This goes in line with previous data 
obtained on macrophages that were shown to produce less IL-6 and TNF-alpha after 
stimulation with the TLR ligands LPS, CPG and PGN. (Kuroda et al., 2008) 
Additionally, our group gained similar results, in vitro as well as in vivo in 
thioglycollate-elicited peritoneal macrophages (unpublished data). 
What was surprising is that IL-10 production also seemed to be reduced in LysMcre 
fl/fl PTEN dendritic cells, which is contrary to the findings in macrophages made by A. 
Suzuki and us (unpublished data) in macrophages. (Kuroda et al., 2008) 
Of particular interest is the expression of IL-12 cytokine family members, namely IL-
12 and IL-23, which are key players in the regulation of T cell responses. (Gee et al., 
2009) These cytokines are mainly produced by monocytes, macrophages and 
dendritic cells as a response to infection. IL-12 and IL-23 share the common p40 
subunit, but differ in their small components, p35 and p19, respectively. Although they 
are quite similar in terms of receptor and subsequent JAK/STAT signalling activation, 
they fulfil highly specific roles in immune regulation. Whereas Il-12 is important in 
production of IFN-gamma and subsequent Th1 cell differentiation, IL-23 has a key 
role in Th17 cell development. (Gee et al., 2009) Concerning the role of the 
PI3K/PTEN pathway in T helper cell development, it has already been demonstrated 
that p85 PI3K knockout mice are resistant to Leishmania infection due to DC 
overproduction of IL-12 and thus excessive Th1 polarization. (Fukao et al., 2002) This 
finding has also been confirmed in the opposite direction as LysMcre PTEN fl/fl mice 
show increased susceptibility and delayed healing as response to Leishmania 
infection.(Kuroda et al., 2008) 
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Due to their important role in T helper cell activation and thus also in autoimmunity, a 
neutralising antibody to IL-12 subunit p40 has been developed for use in multiple 
sclerosis, an autoimmune disease similar to rheumatoid arthritis in terms of inducing 
agents. (Longbrake and Racke, 2009) Subunit p40 antibodies proved to prevent 
autoimmune encephalomyelitis in murine models,(Leonard et al., 1995) but so far, 
Phase II clinical trials failed, probably because only very early disease stages can be 
addressed by the antibody. (Longbrake and Racke, 2009) 
In our myeloid-cell specific PTEN knockout system, mice were also protected from 
RA and in vitro cytokine levels for IL-12 and IL-23 were found to be reduced in BM-
derived DCs. Thus it can be speculated, that there is an effect on T helper cell 
differentiation in PTEN -/- mice.  
As the reduction in IL-12 levels was found to support the view of Fukao et al., who 
show increased IL-12 levels in PI3K p85 alpha knockout mice, we also tried to find 
differences in MAPK signalling which are supposed to be responsible for regulation of 
IL-12 expression. (Fukao et al., 2002) We found reduced levels of phospho p38 as 
well as phospho ERK1/2 upon LPS as well as CpG stimulation. These effects 
demonstrate that hyperactive PI3K signalling leads to decreased levels of mitogen-
activated protein kinases and thus reduced cytokine mRNA induction. (Lu et al., 
1999) 
 
We now conclude that myeloid cell specific PTEN knockout reduces phosphoylation 
of MAPK and as a consequence also reduces proinflammatory cytokine production in 
antigen presenting cells. This presumably results in markedly reduced numbers of 
auto-inflammatory Th1/Th17 cells and thus a better clinical outcome in collagen-
induced arthritis and possibly other immune diseases such as experimental 
autoimmune encephalomyelitis (EAE). 
 
Further projects will now aim to investigate the T helper cell response in PTEN 
knockout animals. On the one hand, if Th17 cells are less abundant, related cytokines 
such as IL-17, IL-21 and IL-22 should also be present in lower amounts in draining 
lymph nodes.  On the other hand, Th2 or Treg cytokine levels such as IL-4 and IL-5 
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might be elevated. Figure 5.1 demonstrates our current view how hyperactive PI3K 
signalling in PTEN deficient myeloid cells regulates adaptive immune responses. 
 
 
Th2
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PI3K
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IL-4
TGFbeta
IL-2
PI3K
 
Figure 5.1: Differentiation of CD4 positive naïve T cells to Th1 and autoinflammatory Th17 cells is 
reduced in PTEN deficient mice whereas Th2 and probably also regulatory T cells are more abundant. 
This happens due to reduced MAPK signalling and subsequent diminished release of proinflammatory 
IL-6, IL-23 and IL-12. (modified from (La Cava, 2009)) 
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